Clinical characteristics of asymptomatic carriers of novel coronavirus disease 2019: A multi-center study in Jiangsu Province

• Main Authors: Jiaxin Chen, Tao Han, Mao Huang, Yi Yang, Futai Shang, Yishan Zheng, Wenjing Zhao, Liang Luo, Xudong Han, Aihua Lin, Hongsheng Zhao, Qin Gu, Yi Shi, Jun Li, Xingxiang Xu, Kexi Liu, Yijun Deng, Enzhi Jia, Quan Cao
• Format: Article
• Language: English
• Published: Taylor & Francis Group 2020-01-01
• Series: Virulence
• Subjects: novel coronavirus disease-19; covid-19; severe acute respiratory syndrome coronavirus 2; sars-cov-2; asymptomatic carriers; immune response; inflammatory marker; disease severity of covid-19
• Online Access: http://dx.doi.org/10.1080/21505594.2020.1840122

Asymptomatic SARS-CoV-2-infected individuals are thought to play major roles in virus transmission. This study aimed to analyze the characteristics of asymptomatic carriers with COVID-19 to control the spread of the virus. We retrospectively investigated the clinical characteristics of 648 consecutive subjects who were enrolled in the study and were divided into asymptomatic carriers, mild cases, ordinary cases, severe or critical cases, and evaluated their impact on disease severity by means of Spearman correlation and multiple regression analyses. Receiver operating characteristic curve analysis was conducted to determine the optimum cutoff levels of laboratory findings for diagnostic predictors of asymptomatic carriers of COVID-19. In our study, a total of 648 subjects on admission with a mean age of 45.61 y including 345 males and 303 females were enrolled in our study. The leukocyte, lymphocyte, eosinophil, platelet, C-reactive protein, interleukin-6, CD3+, CD4+, and CD8 + T lymphocyte levels, and the erythrocyte sedimentation rate differed significantly among the groups (all p ≤ 0.05). Disease severity was negatively associated with the CD3+ (r = −0.340; p < 0.001), CD4+ (r = −0.290; p = 0.001) and CD8+ (r = −0.322; p < 0.001) T lymphocyte levels. The significant diagnostic predictors of asymptomatic carriers of COVID-19 included the blood cell, cytokine, and T lymphocyte subset levels. Inflammation and immune response may play important roles in disease progression. Hence, the laboratory parameters identified should be considered in clinical practice, which provide new insights into the identification of asymptomatic individuals and the prevention of virus transmission.